Cited by 26Wnt/β-catenin signaling in development and cancerLiver physiology and pathologyCancer-related Molecular Pathways

Wnt signaling regulates hepatocyte cell division by a transcriptional repressor cascade

Open access
Jin, Yinhua, Anbarchian, Teni, Wu, Peng, Sarkar, Abby, Fish, Matt, Peng, Weng Chuan, Nusse, Roel·2022·Proceedings of the National Academy of Sciences

Abstract

Cell proliferation is tightly controlled by inhibitors that block cell cycle progression until growth signals relieve this inhibition, allowing cells to divide. In several tissues, including the liver, cell proliferation is inhibited at mitosis by the transcriptional repressors E2F7 and E2F8, leading to formation of polyploid cells. Whether growth factors promote mitosis and cell cycle progression by relieving the E2F7/E2F8-mediated inhibition is unknown. We report here on a mechanism of cell division control in the postnatal liver, in which Wnt/β-catenin signaling maintains active hepatocyte cell division through Tbx3 , a Wnt target gene. The TBX3 protein directly represses transcription of E2f7 and E2f8 , thereby promoting mitosis. This cascade of sequential transcriptional repressors, initiated by Wnt signals, provides a paradigm for exploring how commonly active developmental signals impact cell cycle completion.

AI snapshot

Written from the paper’s full text.

TL;DR

In mouse liver, Wnt signaling induces the transcriptional repressor Tbx3, which represses the mitotic inhibitors E2f7 and E2f8 to permit hepatocyte M-phase progression and maintain diploidy. This defines a transcriptional repressor cascade downstream of Wnt that controls hepatocyte cell division and has implications for tissue homeostasis and disease.

Key findings

  • Tbx3 acts downstream of Wnt signaling in hepatocytes: CRISPR-Cas9 deletion of Apc caused ectopic Tbx3 expression, while Wls knockout led to partial loss of Tbx3.
  • Tbx3 loss slowed cultured hepatocyte proliferation and increased polyploidy; Tbx3 overexpression increased proliferation even without the Wnt activator CHIR99021 and increased the percentage of diploid cells.
  • In vivo, Tbx3 knockout increased polyploid nuclei (>2N: 59.8% in control vs. 92% in Tbx3 KO), while simultaneous deletion of Tbx3, E2f7, and E2f8 restored ploidy and nuclear size to control-like levels.
  • TBX3 bound the E2f7 promoter and E2f8 enhancer by ChIP-seq/ChIP-qPCR; E2f7 and E2f8 transcripts increased upon Tbx3 loss and decreased upon Tbx3 overexpression, and reporter assays confirmed TBX3-mediated repression. Long-term Tbx3 knockout caused fibrosis in five of eight adult KO livers versus none of five controls.

Methods

  • Mouse conditional genetics used Axin2-rtTA/TetO-Cre and Alb-CreERT2 drivers, with doxycycline from postnatal week 2 to week 4 or tamoxifen at P3; Apc was deleted by AAV-delivered CRISPR-Cas9, and Wls was deleted using Cdh5-CreERT2.
  • Primary mouse hepatocytes were cultured under Wnt-dependent expansion conditions and manipulated by lentiviral Tbx3 shRNA knockdown or Sleeping Beauty-mediated Tbx3 overexpression.
  • Analyses included ChIP-seq and ChIP-qPCR, mRNA in situ hybridization, qRT-PCR, luciferase reporter assays in HepG2 cells, flow cytometry for ploidy, nuclear area quantification, and Sirius Red staining for fibrosis.

Limitations

  • The paper states that whether TBX3-high versus TBX3-low pericentral cells differ in Tbx3 function or proliferation rate is unclear, and whether mitosis in periportal hepatocytes is regulated by a periportal signal remains to be studied.
  • The paper notes that Tbx3 is dosage-sensitive in other contexts and that loss of Tbx3 did not affect liver shape or relative mass, despite the later fibrotic phenotype.
  • Evident from the text: human evidence is limited to TBX3 expression patterns and ENCODE ChIP-seq data rather than functional human liver experiments; several in vivo analyses rely on small samples (e.g., n = 3–4 mice, fibrosis in 5/8 KO vs. 0/5 control), and reporter assays were performed in HepG2 cells rather than primary hepatocytes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.2203849119

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

38 of 63 cited sources checked · 19 supported · 1 flagged · accuracy not yet measured

  • Findingcitation

    Human TBX3 protein binds to E2F7 and E2F8 enhancers.

    “Analysis of ChIP-Seq data from the ENCODE database (GSE105374) (33, 34) showed that human TBX3 protein also binds to E2F7 and E2F8 enhancers (SI Appendix, Fig. S3C)”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites GSE105374

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [33] I. Dunham; ENCODE Project Consortium, An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57– 74 (2012). 22955616 PMC3439153 source

      The Genome-wide integration section reports transcription-factor binding at enhancers in general, but does not report TBX3 binding at E2F7 or E2F8 enhancers. Searches for TBX3, E2F7, E2F8, and GSE105374 found no passage in our copy establishing the specific claim. In the citing sentence, the binding result is described as the citing authors’ analysis of ENCODE data. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [34] C. A. Davis, The Encyclopedia of DNA elements (ENCODE): Data portal update. Nucleic Acids Res. 46, D794– D801 (2018). 29126249 PMC5753278 source
  • Findingown data

    Tbx3 seems expressed in a gradient in the pericentral zone.

    “Tbx3, which has been shown to act in a dosage-sensitive manner in other contexts (50), seems to be expressed in a gradient in the pericentral zone (SI Appendix, Fig. S1A).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [50] R. Russell, A dynamic role of TBX3 in the pluripotency circuitry. Stem Cell Reports 5, 1155– 1170 (2015). 26651606 PMC4682344 source
  • Premisecitation

    In mouse and human liver, Wnt ligands are produced by endothelial cells of central vein branches and nearby sinusoids.

    “In the mouse and human liver, Wnt ligands are produced by endothelial cells of the central vein branches and the nearby sinusoids (17–19)”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [17] B. Wang, L. Zhao, M. Fish, C. Y. Logan, R. Nusse, Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature 524, 180– 185 (2015). 26245375 PMC4589224 source

      The Discussion reports Wnt9b expression in central-vein endothelial cells and Wnt2 expression in both central-vein and sinusoidal endothelial cells. The experiments described are in mice; our copy does not establish the same finding in human liver. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [18] L. McEnerney, Dual modulation of human hepatic zonation via canonical and non-canonical Wnt pathways. Exp. Mol. Med. 49, e413 (2017). 29244788 PMC5750478 source

      The Introduction and Discussion describe rodent studies in which central-vein endothelial cells produce Wnt ligands. The Discussion says this still requires validation in human liver, and the paper does not establish production by endothelial cells of nearby sinusoids. Page numbers are unavailable in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [19] L. Zhao, Tissue repair in the mouse liver following acute carbon tetrachloride depends on injury-induced Wnt/β-catenin signaling. Hepatology 69, 2623– 2635 (2019). 30762896 PMC7043939 source

      The Results section (“Upregulation of endogenous and exogenous Wnt ligands”; page not supplied) says that Wnt2 and Wnt9b are expressed by central-vein endothelial cells and that Wnt2 is also expressed by sinusoidal endothelial cells. The paper’s experiments concern mouse liver; our copy does not establish the same claim for human liver. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Premisecitation

    In the liver, E2f7 and E2f8 are responsible for cell cycle arrest that uncouples DNA synthesis from proliferation.

    “In the liver, two members of the E2F family of cell cycle regulators, E2f7 and E2f8, are responsible for this form of cell cycle arrest (7, 8).”
    • Also stated in: § Abstract · plain
      “Therefore, in the liver, DNA synthesis is uncoupled from cell proliferation due to the activity of E2F7 and E2F8.”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [7] H. Z. Chen, Canonical and atypical E2Fs regulate the mammalian endocycle. Nat. Cell Biol. 14, 1192– 1202 (2012). 23064266 PMC3616487 source
    • cites [8] S. K. Pandit, E2F8 is essential for polyploidization in mammalian cells. Nat. Cell Biol. 14, 1181– 1191 (2012). 23064264 source
  • Premisecitation

    Deleting E2f7 and E2f8 from hepatocytes results in completion of M phase and generation of diploid daughter cells.

    “Deleting E2f7 and E2f8 from hepatocytes results in completion of M phase and the generation of diploid daughter cells (7, 8).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [7] H. Z. Chen, Canonical and atypical E2Fs regulate the mammalian endocycle. Nat. Cell Biol. 14, 1192– 1202 (2012). 23064266 PMC3616487 source
    • cites [8] S. K. Pandit, E2F8 is essential for polyploidization in mammalian cells. Nat. Cell Biol. 14, 1181– 1191 (2012). 23064264 source
  • Classified as probably not a substantial claim. 21
  • May combine two claims. 16
  • The quote only partly states this claim. 1
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Tbx3 promotes hepatic progenitor proliferation likely by repressing p19ARF.

    “Tbx3 is required for embryonic liver development and promotes hepatic progenitor proliferation likely by repressing the p19ARF(Cdkn2a) cell cycle inhibitor (23).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [23] T. H. Lüdtke, V. M. Christoffels, M. Petry, A. Kispert, Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation. Hepatology 49, 969– 978 (2009). 19140222 source

      The paper supports a role for Tbx3 in embryonic liver development, but disputes the proposed p19ARF mechanism. In “Proliferation and Migration Defects in the Tbx3-Deficient Liver Bud Are Secondary to Cell Fate Changes” (page not provided), it says p19ARF up-regulation is likely a late consequence of altered cell fate, not the cause of the proliferation defect. (LLM, conf=0.88)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    In the absence of a capacity for cell division, fibrosis becomes a mode of tissue repair and leads to tissue scarring.

    “In the absence of a capacity for cell division, fibrosis becomes a mode of tissue repair and leads to tissue scarring (52, 53).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [52] M. R. Dewhurst, Loss of hepatocyte cell division leads to liver inflammation and fibrosis. PLoS Genet. 16, e1009084 (2020). 33147210 PMC7641358 source

      The Results (page not provided) report elevated liver fibrosis in mice whose hepatocytes cannot divide, and the Discussion (page not provided) describes a pathway from impaired division to fibrosis. The paper does not establish that fibrosis serves as a mode of tissue repair when cells cannot divide generally, or explicitly describe the resulting fibrosis as tissue scarring. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [53] T. Kisseleva, D. Brenner, Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 18, 151– 166 (2021). 33128017 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    E2f7 and E2f8, as well as polyploidy, suppress tumorigenesis.

    “E2f7 and E2f8, as well as polyploidy, are known to suppress tumorigenesis (43–46).”
    Quote in the paperNot a substantial claim4 of 4 sources checked
    • cites [43] L. N. Kent, E2f8 mediates tumor suppression in postnatal liver development. J. Clin. Invest. 126, 2955– 2969 (2016). 27454291 PMC4966321 source

      The Discussion reports that loss of the E2F7/8 repressors leads to hepatocellular carcinoma in mice, and “Tumor suppressive function of E2F8” specifically identifies E2F8 as suppressing cancer initiation in developing livers. The paper also links E2F7/8 loss to reduced hepatocyte ploidy, but the passages do not establish that polyploidy itself suppresses tumorigenesis. Page numbers were not available in our copy. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [44] S. Zhang, The polyploid state plays a tumor-suppressive role in the liver. Dev. Cell 44, 447– 459.e5 (2018). 29429824 PMC5828993 source

      The Results section ('E2f8 knockout and Anln shRNA mice confirmed the protective effects of polyploidy'; page unavailable) reports more liver tumors in E2f8-deficient mice, but attributes the difference chiefly to their lower ploidy rather than to E2f8 itself. The Introduction (page unavailable) mentions E2f7/E2f8 double-knockout livers but does not establish a tumor-suppressive role for E2f7. The source supports polyploidy's protective effect in the liver, not the full claim that both genes and polyploidy each suppress tumorigenesis. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [45] P. D. Wilkinson, Polyploid hepatocytes facilitate adaptation and regeneration to chronic liver injury. Am. J. Pathol. 189, 1241– 1255 (2019). 30928253 PMC6547059 source
    • cites [46] E. Moreno, E2F7 is a potent inhibitor of liver tumor growth in adult mice. Hepatology 73, 303– 317 (2021). 32259305 PMC7898887 source

      The Results section ('E2F7/8 Transgene Induction in Liver Tumors Causes Replication Stress and Inhibits Neoplastic Growth'; page unavailable) says E2f7 and E2f8 overexpression inhibits tumorigenesis in mouse liver tumors. Our copy does not say that polyploidy suppresses tumorigenesis; the References section only lists a study about E2F8's role in polyploidization. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Wnt target genes and key metabolic enzymes have a zonated expression pattern in pericentral hepatocytes.

    “creating a zonated expression pattern of Wnt target genes and key metabolic enzymes in pericentral hepatocytes (20–22).”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [20] S. Benhamouche, Apc tumor suppressor gene is the “zonation-keeper” of mouse liver. Dev. Cell 10, 759– 770 (2006). 16740478 source
    • cites [21] K. B. Halpern, Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature 542, 352– 356 (2017). 28166538 PMC5321580 source
    • cites [22] K. B. Halpern, Paired-cell sequencing enables spatial gene expression mapping of liver endothelial cells. Nat. Biotechnol. 36, 962– 970 (2018). 30222169 PMC6546596 source

      The Discussion (page unavailable) describes pericentrally zonated xenobiotic-metabolism enzymes in hepatocytes, supporting the metabolic-enzyme part of the claim. The Results section on pericentral LECs (page unavailable) says these cells secrete Wnt ligands that maintain hepatocyte zonation, but it does not establish that Wnt target genes themselves have zonated expression in pericentral hepatocytes. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    A role for Wnt signaling during M phase has been suggested based on high Wnt/β-catenin signaling activity during cell division.

    “A role for Wnt signaling during M phase has also been suggested based on high Wnt/β-catenin signaling activity during cell division, through an unknown mechanism (39, 40).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [39] C. Niehrs, S. P. Acebron, Mitotic and mitogenic Wnt signalling. EMBO J. 31, 2705– 2713 (2012). 22617425 PMC3380213 source
    • cites [40] B. W. Benham-Pyle, J. Y. Sim, K. C. Hart, B. L. Pruitt, W. J. Nelson, Increasing β-catenin/Wnt3A activity levels drive mechanical strain-induced cell cycle progression through mitosis. eLife 5, e19799 (2016). 27782880 PMC5104517 source

      The Discussion reports that higher Wnt3A/β-catenin activity drove mechanically strained cells from G2 into mitosis, supporting a suggested role in mitotic progression. It does not establish that signaling activity was high during M phase itself; the reported activity concerns progression into mitosis. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    E2f7 and E2f8 are expressed in several other tissues, such as placenta and pancreas, where they are implicated in arresting the cell cycle.

    “These mitotic inhibitors are expressed in several other tissues, such as the placenta and pancreas, where they are also implicated in arresting the cell cycle (8, 47–49).”
    Quote in the paperNot a substantial claim3 of 4 sources checked
    • cites [8] S. K. Pandit, E2F8 is essential for polyploidization in mammalian cells. Nat. Cell Biol. 14, 1181– 1191 (2012). 23064264 source
    • cites [47] Q. R. Qi, Involvement of atypical transcription factor E2F8 in the polyploidization during mouse and human decidualization. Cell Cycle 14, 1842– 1858 (2015). 25892397 PMC4614110 source

      The Introduction (page not provided) links E2F7 and E2F8 to trophoblast giant cells and describes them as transcriptional repressors. The section “E2F8 initiates the endoreplication of mouse decidual cells” (page not provided) says E2F8 represses mitosis and cytokinesis in decidual cells. Our copy does not establish expression in the pancreas or cell-cycle arrest in the placenta and pancreas. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [48] R. B. Matondo, Atypical E2f functions are critical for pancreas polyploidization. PLoS One 13, e0190899 (2018). 29329320 PMC5766144 source
    • cites [49] M. Mizuno, The role of E2F8 in the human placenta. Mol. Med. Rep. 19, 293– 301 (2019). 30387815 PMC6297733 source

      The Results (page unavailable) show E2F8 expression in the human placenta, but the study did not investigate E2F7 expression there or address expression in the pancreas. Its Results also report that E2F8 silencing did not significantly affect the cell cycle or proliferation in the placental cell line tested, so this paper does not support the attributed role in cell-cycle arrest. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Tbx3 is among the genes highly expressed in the pericentral zone.

    “Among the genes highly expressed in the pericentral zone is the transcriptional repressor Tbx3 (17, 19).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [17] B. Wang, L. Zhao, M. Fish, C. Y. Logan, R. Nusse, Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature 524, 180– 185 (2015). 26245375 PMC4589224 source
    • cites [19] L. Zhao, Tissue repair in the mouse liver following acute carbon tetrachloride depends on injury-induced Wnt/β-catenin signaling. Hepatology 69, 2623– 2635 (2019). 30762896 PMC7043939 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Tbx3 maintains expression of hepatocyte-lineage genes and represses cholangiocyte fate.

    “Tbx3 also maintains expression of hepatocyte-lineage genes, such as Cebpα and Hnf4α, and represses the cholangiocyte fate (23, 24).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [23] T. H. Lüdtke, V. M. Christoffels, M. Petry, A. Kispert, Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation. Hepatology 49, 969– 978 (2009). 19140222 source
    • cites [24] A. Suzuki, S. Sekiya, D. Büscher, J. C. Izpisúa Belmonte, H. Taniguchi, Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression. Development 135, 1589– 1595 (2008). 18356246 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Tbx3 is required for embryonic liver development.

    “Tbx3 is required for embryonic liver development and promotes hepatic progenitor proliferation likely by repressing the p19ARF(Cdkn2a) cell cycle inhibitor (23).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [23] T. H. Lüdtke, V. M. Christoffels, M. Petry, A. Kispert, Tbx3 promotes liver bud expansion during mouse development by suppression of cholangiocyte differentiation. Hepatology 49, 969– 978 (2009). 19140222 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Tbx3 acts as a target of Wnts in other contexts.

    “These findings agree with Tbx3 acting as a target of Wnts in other contexts (25, 27–30).”
    Quote in the paperNot a substantial claim3 of 5 sources checked
    • cites [25] C. A. Renard, Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Cancer Res. 67, 901– 910 (2007). 17283120 source
    • cites [27] N. Aydoğdu, TBX2 and TBX3 act downstream of canonical WNT signaling in patterning and differentiation of the mouse ureteric mesenchyme. Development 145, dev171827 (2018). 30478225 source
    • cites [28] A. Waghray, Tbx3 controls Dppa3 levels and exit from pluripotency toward mesoderm. Stem Cell Reports 5, 97– 110 (2015). 26095607 PMC4618439 source
    • cites [29] M. C. Eblaghie, Interactions between FGF and Wnt signals and Tbx3 gene expression in mammary gland initiation in mouse embryos. J. Anat. 205, 1– 13 (2004). 15255957 PMC1571327 source
    • cites [30] D. Zimmerli, TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. eLife 9, e58123 (2020). 32808927 PMC7434441 source

      The Results and discussion describe TBX3 as a regulator of Wnt target genes, but do not say that TBX3 itself is a target of Wnts in other contexts. Searches for TBX3 as a Wnt target and for Wnt-dependent TBX3 expression found no passage addressing that direction of regulation. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Tbx3 acts in a dosage-sensitive manner in other contexts.

    “Tbx3, which has been shown to act in a dosage-sensitive manner in other contexts (50)”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [50] R. Russell, A dynamic role of TBX3 in the pluripotency circuitry. Stem Cell Reports 5, 1155– 1170 (2015). 26651606 PMC4682344 source
  • May combine two claims.

    Findingown data

    Tbx3 knockdown increases and overexpression decreases E2f7/E2f8 transcripts in cultured hepatocytes.

    “Knockdown and overexpression of Tbx3 in cultured primary hepatocytes further corroborated the interactions with E2f7 and E2f8 (Fig. 3E and F).”
    • Also stated in: § TBX3 Represses Transcription of E2f7 and E2f8. · plain
      “qRT-PCR analysis shows increased E2f7 and E2f8 transcription in Tbx3 KD cultured mouse primary hepatocytes.”
    • Also stated in: § TBX3 Represses Transcription of E2f7 and E2f8. · plain
      “E2f7 and E2f8 are down-regulated upon overexpression of Tbx3.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    TBX3 represses E2f7/E2f8 via binding to their regulatory regions, confirmed by luciferase reporter.

    “Addition of the mouse E2f7 or E2f8 enhancer regions containing the TBX3 binding sites to an HSV-TK reporter construct led to significant repression of the luciferase reporter activity compared to control vector with HSV-TK promoter only (Fig. 3G).”
    • Also stated in: § TBX3 Represses Transcription of E2f7 and E2f8. · boosted
      “reporter activity was increased when TBX3 was knocked down or T-box binding motifs were mutated or deleted from the enhancer regions, confirming that TBX3 is a specific transcriptional repressor of E2f7 and E2f8 (Fig. 3G and SI Appendix, Fig. S3A).”
    Quote in the paperSubstantial claim
  • May combine two claims. The quote only partly states this claim.

    Findingown data

    Tbx3 promotes hepatocyte proliferation and mitotic progression.

    “This resulted in significant slowing down of hepatocyte proliferation (Fig. 1B) and increased numbers of polyploid cells (Fig. 1C and SI Appendix, Fig. S1C and Table S1), suggesting that hepatocytes failed to complete M phase.”
    • Also stated in: § Tbx3 Promotes Hepatocyte Proliferation Downstream of Wnt Signaling. · plain
      “overexpression of Tbx3 in hepatocytes was sufficient to increase proliferation (Fig. 1D and SI Appendix, Fig. S1D and E), even in the absence of CHIR99021”
    • Also stated in: § Deletion of Tbx3 and Changes in Ploidy. · plain
      “Tbx3 regulates polyploidization of hepatocytes in vivo and in vitro by its control over cell division.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Simultaneous deletion of Tbx3, E2f7, and E2f8 restores normal ploidy and nuclear size.

    “GFP-labeled nuclei in Tbx3-E2f7-E2f8 TKO livers were indistinguishable from controls in ploidy and size (Fig. 4B–D and SI Appendix, Table S1).”
    • Also stated in: § Epistatic Relationships between Tbx3 and E2f7/E2f8. · plain
      “simultaneous removal of E2f7, E2f8, and Tbx3 resolves the polyploid phenotype caused by removal of Tbx3 alone.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    TBX3 binds to the E2f7 promoter and the E2f8 enhancer.

    “We found that the TBX3 protein binds to promoter and enhancer regions of E2f7 and E2f8, respectively, and verified this interaction by ChIP-qPCR (Fig. 3A and B).”
    • Also stated in: § TBX3 Represses Transcription of E2f7 and E2f8. · plain
      “TBX3 binds to E2f7 promoter and E2f8 enhancer, shown by ChIP-Seq binding profiles”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    CHIR99021 alone enhances hepatocyte proliferation but less than Tbx3 overexpression.

    “As expected, CHIR99021 alone enhanced proliferation of hepatocytes albeit not to the same degree as Tbx3 overexpression (Fig. 1D).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Tbx3 KO livers have cytoplasmic vacuoles and anomalies in the pericentral zone.

    “Upon histological analysis, we observed cytoplasmic vacuoles and anomalies in the pericentral zone (Fig. 5B).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given

    In the growing and adult liver, Tbx3 is expressed primarily in the pericentral zone.

    “in the growing and adult liver, Tbx3 is expressed primarily in the pericentral zone”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    Loss of Tbx3 is not compatible with long-term homeostatic tissue renewal, likely due to failure in cell division leading to compensatory fibrotic repair.

    “Appearance of fibrotic areas in Tbx3 KO livers suggests that loss of Tbx3 is not compatible with long-term homeostatic tissue renewal, likely due to failure in cell division, which leads to compensatory fibrotic repair.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In hepatic tumor cells with activating β-catenin mutations, Tbx3 is overexpressed and mediates cell proliferation and survival.

    “In hepatic tumor cells with activating β-catenin mutations, Tbx3 is overexpressed and mediates cell proliferation and survival (25).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [25] C. A. Renard, Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Cancer Res. 67, 901– 910 (2007). 17283120 source
  • May combine two claims.

    Interpretationown data

    In the absence of Tbx3, hepatocytes complete S phase but not M phase.

    “The decrease in diploidy and the concomitant increase in polyploidy indicated that in the absence of Tbx3, hepatocytes were able to complete S phase but not M phase.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Genetic interactions imply a linear pathway: Wnt activates Tbx3, which represses E2f7/E2f8, relieving cell cycle arrest and maintaining diploid dividing state.

    “These genetic interactions imply a linear pathway whereby Wnt activates Tbx3, which represses the mitotic inhibitors E2f7 and E2f8; this therefore relieves cell cycle arrest and maintains hepatocytes in a diploid, dividing state.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Wnt/β-catenin signaling controls the G1/S transition.

    “The Wnt/β-catenin signaling pathway is one of the mechanisms known to control G1/S transition (35–38).”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [35] T. C. He, Identification of c-MYC as a target of the APC pathway. Science 281, 1509– 1512 (1998). 9727977 source
    • cites [36] M. Shtutman, The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U.S.A. 96, 5522– 5527 (1999). 10318916 PMC21892 source
    • cites [37] O. Tetsu, F. McCormick, Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422– 426 (1999). 10201372 source
    • cites [38] C. Torre, The transforming growth factor-α and cyclin D1 genes are direct targets of β-catenin signaling in hepatocyte proliferation. J. Hepatol. 55, 86– 95 (2011). 21145869 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Automatically detected hepatocyte nuclei were validated or corrected manually when necessary.

    “Hepatocyte nuclei were detected automatically with the “analyze particles” feature of Fiji (ImageJ) software to encircle GFP- or HNF4α-positive nuclei and selected regions were validated or corrected manually when necessary.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Firefly luciferase activity was normalized to Renilla luciferase in each sample.

    “Firefly luciferase activity was normalized to Renilla luciferase in each sample.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Quiescence is commonly imposed by inhibitors that prevent cells from entering S phase.

    “Quiescence is commonly imposed by inhibitors that prevent cells from entering S phase (2).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [2] B. D. Manning, L. C. Cantley, AKT/PKB signaling: Navigating downstream. Cell 129, 1261– 1274 (2007). 17604717 PMC2756685 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Doublets were excluded from flow cytometry analysis by forward-scatter width/height and side-scatter width/height gating.

    “Doublets were excluded by forward-scatter width (FSC-W)/ forward-scatter height (FSC-H) and side-scatter width (SSC-W) / side-scatter height (SSC-H) analysis.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Cells in adult tissues remain mostly quiescent unless activated by growth factors.

    “Cells in adult tissues remain mostly quiescent unless they become activated by growth factors to enter the cell cycle and proliferate (1).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [1] S. M. Jones, A. Kazlauskas, Growth factor-dependent signaling and cell cycle progression. FEBS Lett. 490, 110– 116 (2001). 11223025 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Growth factors repress inhibitors and activate the G1/S transition to allow cell cycle entry.

    “To allow cell cycle entry, growth factors repress these inhibitors and activate the G1/S transition (3).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [3] H. A. Coller, What’s taking so long? S-phase entry from quiescence versus proliferation. Nat. Rev. Mol. Cell Biol. 8, 667– 670 (2007). 17637736 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    Single-stained channels were used for compensation and a fluorophore-minus-one control was used for gating in flow cytometry.

    “Single-stained channels were used for compensation and fluorophore minus one control was used for gating.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    A rat IgG1 isotype control was used as the IgG control in chromatin immunoprecipitation.

    “Rat IgG1 isotype control (Thermo Fisher MA1-90035) was used for IgG control.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Gapdh promoter primers were used as internal controls in ChIP-qPCR.

    “Forward: 5′-AAGGTCATCCCAGAGCTGAA-3′ and reverse: 5′-CTGCTTCACCACCTTCTTGA-3′ primers detecting Gapdh promoter area were used as internal controls.”
    Quote in the paperNot a substantial claim
33 of 33
  • The authors state this as an assumption.

    Whether mechanisms analogous to S-phase repressors operate in M phase was unknown.

    “It was unknown whether similar mechanisms operate in the M phase.”
    “Whether growth factors can suppress the activity of E2f7 and E2f8 and thereby promote cell division is currently not known.”
  • The paper relies on this without support.

    CHIR99021 activates Wnt signaling by inhibiting GSK3.

    “CHIR99021, a GSK3 inhibitor that activates Wnt signaling”
2 of 2

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • E2f8 TBX3-binding site is called both an enhancer and a promoter

    Minor

    The results identify the tested E2f8 TBX3-binding site as an enhancer, whereas the ChIP-qPCR methods call the E2f8 site a promoter area.

1 of 1

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

  • Cites a retracted work: 10.3727/096504017x15145624664031

    Info

    The cited work was retracted on 2026-09-14 (notice 10.32604/or.2026.092122), not before this paper was published (2022-07-22).

    Cited work 10.3727/096504017x15145624664031 · retracted 2026-09-14 · notice 10.32604/or.2026.092122 · this paper published 2022-07-22

1 of 1

Cites

1 retracted

Flagged first, then by citations

2 of the 73 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Y. Jin R. Nusse W. Zhou Wnt Signaling Regulates Hepatocyte Cell Division by aTranscriptional Repressor Cascade. GEO. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE205339. Deposited 1 June 2022.

Cited by

Sorted by citations

Authors
Jin, Y., Anbarchian, T., Wu, P., Sarkar, A., Fish, M., Peng, W. C., & Nusse, R.
Affiliations
  • Howard Hughes Medical Institute (US)
  • Department of Developmental Biology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305
Venue
Proceedings of the National Academy of Sciences
Published
2022-07-22
Volume
119
Issue
30
Pages
e2203849119-e2203849119
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4286587461
Cited by
26
References
73
Citations by year
2026: 3 · 2025: 8 · 2024: 6 · 2023: 4 · 2022: 5
FWCI
1.59
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by)
Funders
Howard Hughes Medical Institute (no number)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
Wnt/β-catenin signaling, TBX3, E2F7, E2F8, transcriptional repression, cell cycle progression, polyploidy, postnatal liver development, mitosis
MeSH terms
Animals, Mitosis, Repressor Proteins, T-Box Domain Proteins, Hepatocytes, beta Catenin, Mice, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-22.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-22.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review